Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

OBJECTIVES: This review examines the burden and patterns of disease in systemic lupus
erythematosus (SLE) and the influence and interactions of gender, ethnicity, age, and …

Background and aims We studied damage accrual and factors determining development
and progression of damage in an international cohort of systemic lupus erythematosus …

Background Premature coronary artery disease is a major cause of illness and death in
patients with systemic lupus erythematosus, but little is known about the prevalence, extent …

Clinical and laboratory manifestations and outcome of systemic lupus erythematosus (SLE)
may vary in different populations. A prospective multinational inception cohort should prove …

Objectives The impact of corticosteroids on the risk of organ damage in the context of clinical
end points endorsed in some systemic lupus erythematosus (SLE) clinical trials is …

Abstract Objective The Systemic Lupus International Collaborating Clinics/American College
of Rheumatology (ACR) Damage Index (SDI) is the accepted measure of permanent organ …

Данные клинические рекомендации подготовлены совместно с Всероссийской
ассоциацией для больных муковисцидозом, рассмотрены и утверждены на заседании …

OBJECTIVE: To determine the pattern of accumulation of damage in an inception cohort of
patients with systemic lupus erythematosus (SLE) followed yearly for at least 15 years, and …

Measurement of disease activity in systemic lupus erythematosus (SLE) is central to
evaluating outcomes, differences among SLE patient groups, responses to a new drug …